PALVELLA THERAPEUTICS, INC. (PVLA)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 7, 2026

Verified against EDGAR
Total Assets
$253.5M
Stockholders' Equity
$216.9M
Cash & Equivalents
$187.8M
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, PALVELLA THERAPEUTICS, INC. reported net income of -$21.9M and total assets of $253.5M. Every figure below is taken directly from PALVELLA THERAPEUTICS, INC.'s SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2016–FY2023 · as reported

$46.3M$270,500-$45.7M
FY2016FY2018FY2020FY2022FY2023
Revenue$42.8MNet income$18.7M
FY2016 revenue
$5.8M
FY2023 revenue
$42.8M

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025—-$41.7M
FY2024—-$17.4M
FY2023$42.8M$18.7M
FY2022$25.9M-$33.3M
FY2021$31.4M-$45.7M
FY2020$29.3M-$37.2M
FY2019$46.3M-$25.5M
FY2018$29.1M-$26.8M
FY2017$25.3M-$17.6M
FY2016$5.8M-$22.8M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KOct 28, 2026on EDGAR ↗
8-KAug 4, 2026on EDGAR ↗
10-QAug 4, 2026on EDGAR ↗
8-KJul 14, 2026on EDGAR ↗
8-KJun 30, 2026on EDGAR ↗
8-KJun 16, 2026on EDGAR ↗
8-KMay 20, 2026on EDGAR ↗
8-KMay 15, 2026on EDGAR ↗
8-KMay 13, 2026on EDGAR ↗
10-QMay 7, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$253.5Msource ↗
Stockholders’ Equity$216.9Msource ↗
Cash & Equivalents$187.8Msource ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue—source ↗
Net Income-$21.9Msource ↗
Operating Income-$21.4Msource ↗
Gross Profit—source ↗
Cost of Revenue—source ↗
R&D Expense$12.5Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$-1.52source ↗
EPS (basic)$-1.52source ↗
Shares Outstanding14.4Msource ↗
Cash from Operations-$12.8Msource ↗
Cash from Financing$1.3Msource ↗
Cash from Investing-$7.0Msource ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
0
Sells
48
Net shares
-81.1K

Restatement history

Point-in-time

20 of 326 annual fact-keys were materially restated between filings: what PALVELLA THERAPEUTICS, INC. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.

See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.

Deeper fundamentals

A free API key reaches PVLA’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/PVLA

MCP tool: get_sec_fundamentals ticker=PVLA

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/PVLA/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=PVLA as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/PVLA/history

MCP tool: get_fundamentals_history ticker=PVLA

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/PVLA

MCP tool: get_financial_health ticker=PVLA

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.